DK124290A - Midler og fremgangsmaader til administrering af terapeutisk aktive forbindelser - Google Patents

Midler og fremgangsmaader til administrering af terapeutisk aktive forbindelser Download PDF

Info

Publication number
DK124290A
DK124290A DK124290A DK124290A DK124290A DK 124290 A DK124290 A DK 124290A DK 124290 A DK124290 A DK 124290A DK 124290 A DK124290 A DK 124290A DK 124290 A DK124290 A DK 124290A
Authority
DK
Denmark
Prior art keywords
organic anions
procedures
methods
administering therapeutic
therapeutic active
Prior art date
Application number
DK124290A
Other languages
English (en)
Other versions
DK124290D0 (da
DK175783B1 (da
Inventor
Richard G Markham
Original Assignee
Oxycal Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/246,504 external-priority patent/US4968716A/en
Priority claimed from PCT/US1989/001642 external-priority patent/WO1990012571A1/en
Application filed by Oxycal Lab Inc filed Critical Oxycal Lab Inc
Publication of DK124290A publication Critical patent/DK124290A/da
Publication of DK124290D0 publication Critical patent/DK124290D0/da
Application granted granted Critical
Publication of DK175783B1 publication Critical patent/DK175783B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DK199001242A 1988-09-19 1990-05-18 Midler og fremgangsmåder til administrering af terapeutisk aktive forbindelser DK175783B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US07/246,504 US4968716A (en) 1987-04-10 1988-09-19 Compositions and methods for administering therapeutically active compounds
US24650488 1988-09-19
PCT/US1989/001642 WO1990012571A1 (en) 1989-04-07 1989-04-07 Compositions and methods for administering vitamin c
US8901642 1989-04-07
US8904046 1989-09-15
PCT/US1989/004046 WO1990003167A1 (en) 1988-09-19 1989-09-15 Compositions and methods for administering therapeutically active compounds

Publications (3)

Publication Number Publication Date
DK124290A true DK124290A (da) 1990-05-18
DK124290D0 DK124290D0 (da) 1990-05-18
DK175783B1 DK175783B1 (da) 2005-02-21

Family

ID=22930954

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199001242A DK175783B1 (da) 1988-09-19 1990-05-18 Midler og fremgangsmåder til administrering af terapeutisk aktive forbindelser

Country Status (16)

Country Link
EP (1) EP0417209B1 (da)
JP (1) JP2973365B2 (da)
AT (1) ATE160939T1 (da)
CA (1) CA1341434C (da)
DE (1) DE68928488T2 (da)
DK (1) DK175783B1 (da)
FI (1) FI97950C (da)
HU (1) HU905911D0 (da)
NO (1) NO178056C (da)
NZ (1) NZ230700A (da)
PL (1) PL165416B1 (da)
RO (1) RO108148B1 (da)
RU (1) RU2059410C1 (da)
WO (1) WO1990003167A1 (da)
YU (1) YU47746B (da)
ZA (1) ZA904494B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ511396A (en) * 1999-08-30 2003-08-29 Oxycal Lab Inc Compositions containing a metal salt of ascorbic acid for selective cancer chemotherapy
AT501682A1 (de) 2005-01-14 2006-10-15 Hermine Dr Engl Verfahren zur herstellung einer wirkstoffmischung
FI20095278A0 (fi) 2009-03-18 2009-03-18 Valtion Teknillinen Ksylonihapon valmistus
KR101037125B1 (ko) * 2009-05-14 2011-05-26 계명대학교 산학협력단 바이오에탄올 생산을 위한 바이오매스 전처리법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2606903A (en) * 1944-03-29 1952-08-12 Physiological Chemicals Compan Ascorbic acid addition compound of sulfathiazole
US2822317A (en) * 1955-12-12 1958-02-04 Smith Kline French Lab Aqueous iron-ascorbic acid preparation
GB2040164A (en) * 1979-01-31 1980-08-28 Beecham Group Ltd Compositions containing paracetamol
US4822816A (en) * 1987-04-10 1989-04-18 Oxycal Laboratories, Inc. Compositions and methods for administering vitamin C

Also Published As

Publication number Publication date
AU621672B2 (en) 1992-03-19
FI902461A0 (fi) 1990-05-18
FI97950B (fi) 1996-12-13
EP0417209A1 (en) 1991-03-20
NO178056B (no) 1995-10-09
NZ230700A (en) 1992-07-28
DE68928488T2 (de) 1998-04-02
CA1341434C (en) 2003-07-08
DE68928488D1 (de) 1998-01-22
ZA904494B (en) 1991-03-27
RO108148B1 (ro) 1994-02-28
EP0417209A4 (en) 1992-01-08
WO1990003167A1 (en) 1990-04-05
JPH03504502A (ja) 1991-10-03
HU905911D0 (en) 1991-03-28
FI97950C (fi) 1997-03-25
PL165416B1 (pl) 1994-12-30
RU2059410C1 (ru) 1996-05-10
NO902132D0 (no) 1990-05-14
AU4328889A (en) 1990-04-18
ATE160939T1 (de) 1997-12-15
DK124290D0 (da) 1990-05-18
DK175783B1 (da) 2005-02-21
NO178056C (no) 1996-01-17
YU47746B (sh) 1996-01-08
YU117890A (sh) 1993-10-20
NO902132L (no) 1990-05-14
EP0417209B1 (en) 1997-12-10
JP2973365B2 (ja) 1999-11-08

Similar Documents

Publication Publication Date Title
AU576365B2 (en) Collagen and or fibrinogen as carrier of drugs for their introduction into cellular lesion areas
FI875308A0 (fi) Foerfarande i tvao steg foer att hela ett saor smaertfritt och ett vattenhaltigt medium och en salva foer lokal anvaendning vid foerfarandet.
NO904378D0 (no) Fremgangsmaate for fremstilling av et modifisert protein for terapeutisk anvendelse.
AU8091787A (en) The use of paroxetine to treat pain
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
HU213677B (en) Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
MY104006A (en) 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases.
ATE83153T1 (de) Einen gewebe-plasminogen-aktivator enthaltende zusammensetzung.
DK124290A (da) Midler og fremgangsmaader til administrering af terapeutisk aktive forbindelser
ES2066134T3 (es) Usos farmaceuticos de acidos grasos.
DK391089D0 (da) Thiazolforbindelser og fremgangsmaader til fremstilling deraf
DE3650368T2 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
SU1094610A1 (ru) Способ лечени ожоговой болезни
ATE49958T1 (de) Pharmazeutische zusammensetzungen mit immunodepressivwirkung.
WO1990006116A3 (de) Mittel zur behandlung von chronisch entzündlichen darmerkrankungen
RU97101420A (ru) Способ лечения тонзиллита
RU98111356A (ru) Способ лечения ожогового шока
HUT50438A (en) Process for production of medical compositions containing as active substance 2-/2-methil-4-chlor-phenilimin/-imidasolidine

Legal Events

Date Code Title Description
PUP Patent expired